Early Rhythm Control Reduces Mortality among Diabetes Patients with AF
In a recent study published in Diabetes Research and Clinical Practice found that early rhythm control (ERC) significantly impacts the occurrence of diabetes-related complications and mortality in subjects with type 2 diabetes mellitus (T2DM) and atrial fibrillation (AF).
The study included 47,509 subjects with T2DM and AF and based on the Korean National Health Insurance Service claims database spanning from 2009 to 2016. Subjects were divided into two groups – those who received ERC within one year of AF diagnosis and those who underwent usual care.
Among the participants (with a mean age of 66.7±10.5 years), 23.1% received ERC, while 76.9% received usual care. ERC was associated with a notable reduction in the risk of ischemic stroke, macrovascular and microvascular complications, and all-cause death. The adjusted hazard ratios were impressive: 0.77 [0.70–0.85], 0.79 [0.73–0.86], 0.86 [0.82–0.90], and 0.92 [0.87–0.98] respectively, with all p-values below 0.001, except for all-cause death which was 0.012.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.